Total Payments
$968,535
2024 Payments
$94,321
Companies
29
Transactions
1,242
Payment Breakdown by Category
Consulting$543,719 (56.1%)
Other$292,605 (30.2%)
Travel$92,803 (9.6%)
Food & Beverage$27,390 (2.8%)
Research$11,466 (1.2%)
Education$493.05 (0.1%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $543,719 | 217 | 56.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $271,555 | 152 | 28.0% |
| Travel and Lodging | $92,803 | 342 | 9.6% |
| Food and Beverage | $27,390 | 487 | 2.8% |
| Unspecified | $11,466 | 17 | 1.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $9,300 | 5 | 1.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $8,250 | 3 | 0.9% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $3,500 | 2 | 0.4% |
| Education | $493.05 | 16 | 0.1% |
| Gift | $59.40 | 1 | 0.0% |
Payments by Type
General
$957,069
1,225 transactions
Research
$11,466
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $311,047 | 391 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $173,549 | 232 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $156,042 | 108 | $0 (2024) |
| Lilly USA, LLC | $125,903 | 199 | $0 (2024) |
| Eli Lilly and Company | $76,876 | 97 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $43,134 | 109 | $0 (2024) |
| Embecta Corp. | $15,563 | 4 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $11,383 | 7 | $0 (2022) |
| GlaxoSmithKline, LLC. | $10,780 | 13 | $0 (2023) |
| SANOFI PASTEUR INC. | $9,170 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $94,321 | 146 | Lilly USA, LLC ($47,471) |
| 2023 | $134,295 | 192 | Abbott Laboratories ($44,205) |
| 2022 | $178,461 | 255 | Bayer HealthCare Pharmaceuticals Inc. ($93,289) |
| 2021 | $150,286 | 147 | Bayer HealthCare Pharmaceuticals Inc. ($51,133) |
| 2020 | $122,337 | 95 | Abbott Laboratories ($58,070) |
| 2019 | $103,618 | 136 | Abbott Laboratories ($59,770) |
| 2018 | $114,641 | 145 | Abbott Laboratories ($52,464) |
| 2017 | $70,575 | 126 | Abbott Laboratories ($21,584) |
All Payment Transactions
1,242 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $58.71 | General |
| Category: Diabetes Care | ||||||
| 12/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: DIABETES | ||||||
| 12/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,175.00 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $68.67 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $55.30 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $453.23 | General |
| 12/10/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $231.22 | General |
| 12/10/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $151.12 | General |
| 12/10/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $123.90 | General |
| 12/10/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $113.22 | General |
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $79.98 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes Care | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,998.50 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $626.34 | General |
| 10/16/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $240.34 | General |
| 10/16/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $194.14 | General |
| 10/16/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $194.14 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A randomized, open-label, parallel group real world pragmatic trial to assess the clinical and health outcomes of Toujeo compared to commercially available basal insulins for initiation of therapy in | SANOFI-AVENTIS U.S. LLC | $5,745 | 7 |
| Real-world insulin treatment persistence and health resource utilization in T2DM initiating or switching to Gla-300 | SANOFI-AVENTIS U.S. LLC | $2,750 | 5 |
| A Randomized, Open-label, Parallel Group Real World Pragmatic Trial to Assess the Clinical and Health Outcomes of Toujeo Compared to Commercially Available Basal Insulins for Initiation of Therapy in Insulin-naive Patients With Uncontrolled Type 2 Diabetes Mellitus | SANOFI-AVENTIS U.S. LLC | $2,000 | 3 |
| A Randomized, Open-label, Parallel Group Real World Pragmatic Trial to Assess the Clinical and Health Outcomes of Toujeo Compared to Commercially Available Basal Insulins for Initiation of Therapy in Insulin-naive Patients | SANOFI-AVENTIS U.S. LLC | $516.86 | 1 |
| AchieveControl AMCPNx pst; A randomized prospective pragmatic real-world (RW) clinical trial of insulin glargine 300 U/mL (Gla-300) vs other basal insulins (BIs) in insulin-naive patients with type 2 | SANOFI-AVENTIS U.S. LLC | $454.29 | 1 |
About Dr. Eugene Wright, M.D
Dr. Eugene Wright, M.D is a Internal Medicine healthcare provider based in Fayetteville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1528197555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Wright, M.D has received a total of $968,535 in payments from pharmaceutical and medical device companies, with $94,321 received in 2024. These payments were reported across 1,242 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($543,719).
Ad
Practice Information
- Specialty Internal Medicine
- Location Fayetteville, NC
- Active Since 03/05/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1528197555
Products in Payments
- Kerendia (Drug) $147,630
- FreeStyle Libre Pro (Device) $133,283
- JARDIANCE (Drug) $130,845
- TOUJEO (Drug) $48,411
- FreeStyle Libre (Device) $46,916
- FREESTYLE LIBRE (Device) $44,148
- TOUJEO (Biological) $42,475
- MOUNJARO (Drug) $39,874
- SOLIQUA (Drug) $33,577
- FREESTYLE LIBRE 3 (Device) $22,594
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $19,054
- FreeStyle Freedom Lite system (Device) $14,182
- Non-Covered $12,283
- FreeStyle Lite system (Device) $9,725
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $8,484
- FREESTYLE LIBRE 2 (Device) $7,139
- FREESTYLE LIBRE PRO (Device) $7,000
- Non-Covered (Drug) $6,976
- ADLYXIN (Biological) $3,846
- EVERSENSE E3 SENSOR KIT - RETAIL (Device) $3,342
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fayetteville
Catherine Kilpatrick, M.d, M.D
Internal Medicine — Payments: $777,138
Internal Medicine $777,138
Dr. Nicole Greyshock, Md, MD
Internal Medicine — Payments: $387,661
Internal Medicine $387,661
Dr. Frederick Asare, Md, MD
Internal Medicine — Payments: $59,642
Internal Medicine $59,642
Sandip Patel, Md, MD
Internal Medicine — Payments: $42,449
Internal Medicine $42,449
Dr. Hari Saini, M.d, M.D
Internal Medicine — Payments: $33,331
Internal Medicine $33,331
Dr. Sumedha Dalvi, M.d, M.D
Internal Medicine — Payments: $31,724
Internal Medicine $31,724